|
|
|
|
|
Last Trade
|
Last Trade:
$10.52
|
Change:
-0.50 (-4.54%)
|
Trade Time:
Jun 02
|
Market Cap:
$753.08M
|
|
|
|
|
|
|
Description of Business
|
|
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell
immunotherapy company that is developing novel treatments for patients with
cancer, autoimmune and viral diseases. We have several T-cell immunotherapies in
clinical development and are progressing a next-generation allogeneic chimeric
antigen receptor T-cell, or CAR T program.
|
|
|
|